Objective: This study aimed to analyze the top 100 most cited papers in the field of pelvic organ prolapse by utilizing bibliometric methods. Methods: On the 1st of October 2022, articles with the title pelvic organ prolapse were listed in order of citation on the Web of Science database. The first 100 articles were included in the study without a publication time limit. The number of citations, number of citations/year, title, author, journal, publication year, country and institutional information of the articles were recorded. Results: The highest number of citations in the first 100 most cited studies was 3,081 while the lowest was 95. The mean total number of citations of the 100 most cited studies was 248.7±380.2. The annual mean number of citations of the studies ranged between 118.5 and 3.7 and the mean number of studies was 16.8±17.8. In the ranking of the most cited papers, three journals were included in the list 70 times in total, accounting for 70% of the articles. Pelvic floor exercises were mentioned in 27 articles in total. Conclusions: This study provides medical researchers with bibliometric information relating to pelvic organ prolapse. The United States was clearly ahead in our study in terms of first authors, institutions, and journals. Articles on incontinence had more citations per year. Pelvic organ prolapse has serious sociological and economic consequences. We anticipate an increase in research on preventive factors such as pelvic exercise in the future.
27 January 2023 in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
Objective: This study was conducted to evaluate the rates of postpartum depression by using Edinburgh Postpartum Depression Scale among mothers who visited our clinics 6-8 weeks after giving birth, and the effects of some sociodemographic and obstetrical factors on postpartum depression. Materials and methods: This cross-sectional study included 318 women who gave birth 6-8 weeks ago and visited obstetrical and gynecology or pediatrics clinics for routine control. Some sociodemographic and obstetrical data which were thought to be a potential risk factor for postpartum depression were recorded and Edinburgh postpartum Depression Scale was conducted for each patient. Results: 104 patients (32.7%) were diagnosed with postpartum depression. Postpartum depression rates were significantly higher in patients with low education levels and occupations of both mothers and their partners, depression history, dissatisfaction from marriage, smoking, increased number of parity and abortion, unplanned pregnancy, nausea and emesis during pregnancy, birth before 36 week pregnancy, increase in length of hospitalization, baby care in incubator, insufficient support and lack of breastfeeding. Conclusion: There is a significant relationship between some sociodemographic and obstetrical conditions and postpartum depression. Identification of the risk groups and early precautions can reduce the high prevalence of the disease during the pandemic.
14 October 2022 in Journal of Obstetrics and Gynaecology Research
The goal of this study was to identify the demographic, clinical, and laboratory characteristics of primary dysmenorrhea (PD) patients, as well as to compare the treatment options of 200 mg magnesium citrate (MgS) and combination oral contraceptive (COC) therapy. This is a case-controlled prospective study consisting of 172 women with PD and a control group consisting of age-matched 172 without PD. The cases in the primary dysmenorrhea group were randomly divided into two groups, with 86 patients in the first group receiving 200 mg MgS, and 86 patients in the second group receiving COC treatment. The Visual Analogue Scale (VAS) was used to measure the severity of dysmenorrhea. VAS scoring was performed on the control group subjects included in the study at their first evaluation and the PD group subjects before treatment and at the third month of treatment (after three menstrual cycles). When compared to healthy controls, the PD patients had significantly more menstrual bleeding (p = 0.005), more history of maternal dysmenorrhea (p < 0.001), lower serum calcium (p < 0.001), lower serum 25-hydroxyvitamin D3 (p < 0.001) and more 25-hydroxyvitamin D deficiency (p < 0.001). When compared to the MgS group, the patients in the COC group had significantly lower VAS scores and less need for painkillers following treatment (p < 0.001). The MgS treatment group had significantly lower post-treatment VAS values than pre-treatment VAS values. Lower serum calcium and 25-hydroxyvitamin D levels were found in the presence of PD. In addition, it was observed that the administration of 200 mg MgS to PD patients significantly reduced pelvic pain in dysmenorrhea, although not as much as COC administration, and caused significant reductions in the need for painkillers.
6 November 2024 in Journal of Biochemical and Molecular Toxicology
This study aimed to investigate the effects of levonorgestrel-releasing intrauterine device (LNG-IUD) treatment on ovarian reserve in women of reproductive age diagnosed with menorrhagia. This was a prospective controlled trial involving 50 women with menorrhagia and a control group comprising age-matched 50 healthy women. Women who satisfied the LNG group criteria underwent an endometrial pipelle biopsy and LNG-IUD insertion. Ovarian reserve tests were performed prior to and six months after LNG-IUD insertion in the LNG group cases. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), anti-Müllerian hormone (AMH), endometrial thickness (ET), total antral follicle count (AFC), and mean ovarian volume values before LNG-IUD insertion did not differ between the LNG and control groups. When the final measurements were compared, FSH, AMH, total AFC, and average ovarian volume increased (p=0.05, 0.046, 0.022, and 0.022, respectively), E2 and ET decreased (p=0.034 and 0.001, respectively) in the LNG group, while LH did not differ significantly between the groups (p=0.71). We observed that LNG-IUD use effectively improves fertility capacity. In this study, LNG-IUD use in reproductive-age women diagnosed with menorrhagia decreased E2 levels, did not change LH levels, and increased FSH, AFC, and AMH levels.